FDA Adverse Event Injury Summary report: N

EVIS PLEURA VIDEOSCOPE

MDR report key: 14073649 · Received April 11, 2022

Report

Report Number
8010047-2022-06031
Event Type
Injury
Date Received
April 11, 2022
Date of Event
May 11, 2018
Report Date
May 20, 2022
Manufacturer
OLYMPUS MEDICAL SYSTEMS CORP.
Product Code
EWY
PMA / PMN Number
K013617
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TW
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE SUSPECT DEVICE HAS NOT BEEN RETURNED TO OLYMPUS FOR EVALUATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED WITH DEVICE EVALUATION RESULTS.

Additional Manufacturer Narrative · 0

CORRECTION B3: EVENT DATE UPDATED TO REFLECT ONLINE PUBLICATION DATE OF SOURCE ARTICLE. THIS REPORT IS BEING SUPPLEMENTED TO PROVIDE ADDITIONAL INFORMATION BASED ON THE LEGAL MANUFACTURER'S FINAL INVESTIGATION. THE DEVICE HISTORY RECORD WAS UNABLE TO BE REVIEWED FOR THIS DEVICE SINCE THE LOT NUMBER WAS NOT PROVIDED. HOWEVER, OLYMPUS ONLY RELEASES PRODUCTS TO MARKET THAT MEET ALL MANUFACTURING SPECIFICATIONS AND FINAL PRODUCT RELEASE CRITERIA. BASED ON THE RESULTS OF THE INVESTIGATION, THE RELATIONSHIP BETWEEN THE DEVICE AND THE ADVERSE EVENT CANNOT BE CONFIRMED. THERE WAS NO COMPLAINT REPORTED ON THE SUBJECT DEVICE. THERE IS NO EVIDENCE OF AN OLYMPUS DEVICE MALFUNCTION. OLYMPUS WILL CONTINUE TO MONITOR FIELD PERFORMANCE FOR THIS DEVICE.

Description of Event or Problem · 0

OLYMPUS REVIEWED THE FOLLOWING LITERATURE: "BEDSIDE PLEUROSCOPY IN THE INTENSIVE CARE UNIT" BY HEAN OOI.   THIS STUDY RETROSPECTIVELY ANALYZED THE DATA FROM A CONSECUTIVE CASE SERIES, AND EXAMINED THE COMPLICATIONS AND OUTCOMES FOLLOWING BEDSIDE PLEUROSCOPY IN PATIENTS WITH UNDIAGNOSED PLEURAL EFFUSION WITH ACUTE RESPIRATORY FAILURE. A TOTAL OF 25 PATIENTS UNDERWENT PLEUROSCOPIC PROCEDURES AT THE BEDSIDE, AND WERE ROUTINELY MONITORED AND RECORDED FOR ANY MAJOR AND MINOR COMPLICATIONS. THE STUDY REPORTED THAT FIFTEEN PATIENTS (60%) HAD MALIGNANCIES, OF WHOM 11 HAD LUNG CANCER, AND ONE EACH HAD BREAST CANCER, ESOPHAGEAL CANCER, HEPATOMA, AND A MALIGNANT MEDIASTINAL TUMOR. A TOTAL OF 11 (44%) PATIENTS SUFFERED ANY COMPLICATIONS, BUT NO MAJOR COMPLICATIONS WERE REPORTED. THE STUDY CONCLUDED THAT THE PLEUROSCOPY PERFORMED AT THE BEDSIDE IN AN ICU WITH LOCAL ANALGESIA WAS AN EASY AND WELL-TOLERATED PROCEDURE, AND COULD BE USED FOR PATIENTS IN CRITICAL CONDITION.     TYPE OF ADVERSE EVENTS/NUMBER OF PATIENTS: SUBCUTANEOUS EMPHYSEMA - (3): ALL PATIENTS HAD 16 F PIG-TAIL CATHETHER DRAINS AFTER THE PROCEDURE THROUGH THE SAME ENTRY PORT AS THE PLEUROSCOPY TO AVOID THE SPREAD OF SUBCUTANEOUS EMPHYSEMA. HYPOTENSION (PERIPROCEDURE) - (1): NOTED DURING THE PROCEDURE WAS ALSO CORRECTABLE WITH ADEQUATE HYDRATION. THIS ARTICLE INCLUDES 2 REPORTS: PATIENT IDENTIFIER (B)(6): LTF-160, PATIENT IDENTIFIER (B)(6): LTF-240. THIS REPORT IS 2 OF 2 FOR PATIENT IDENTIFIER (B)(6): LTF-240.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2488965 EVIS PLEURA VIDEOSCOPE FLEX DEFLECTABLE VIDEOSCOPE EWY OLYMPUS MEDICAL SYSTEMS CORP. LTF-240

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other